Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Invion (IVIXD)
OTHER OTC:IVIXD
Holding IVIXD?
Track your performance easily
IVIXD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.01
Volume0.00
Average Volume (3M)N/A
Market Cap
$9.77M
Enterprise Value$4.23M
Total Cash (Recent Filing)AU$8.47M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta1.24
Next Earnings
Mar 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares OutstandingN/A
10 Day Avg. Volume200
30 Day Avg. VolumeN/A
Standard Deviation1.11
R-Squared0.17
Alpha0.09
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)11.40
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
IVIXD FAQ
What was Invion’s price range in the past 12 months?
Currently, no data Available
What is Invion’s market cap?
Currently, no data Available
When is Invion’s upcoming earnings report date?
Invion’s upcoming earnings report date is Mar 04, 2025 which is in 101 days.
How were Invion’s earnings last quarter?
Invion released its earnings results on Aug 30, 2024. The company reported -$0.05 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.05.
Is Invion overvalued?
According to Wall Street analysts Invion’s price is currently Overvalued.
Does Invion pay dividends?
Invion does not currently pay dividends.
What is Invion’s EPS estimate?
Invion’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Invion have?
Invion has 68,165,920 shares outstanding.
What happened to Invion’s price movement after its last earnings report?
Invion reported an EPS of -$0.05 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Invion?
Currently, no hedge funds are holding shares in IVIXD
---
Invion Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
-33.81%
Trailing 12-Months
Asset Growth
-18.61%
Trailing 12-Months
Company Description
Invion
Invion Ltd a clinical-stage drug development company, develops treatments for cancer. It develops a novel PhotoDynamic Therapy (PDT) for cancer. The company has produced a topical and intravenous product suitable for use in skin cancer and in solid tumours, such as ovarian, prostate and lung cancer.
---
---